Overview

Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the safety and efficacy of voclosporin as therapy in subjects with active noninfectious uveitis involving the intermediate and/or posterior segments of the eye (i.e., anterior + intermediate-, intermediate-, posterior- or pan-uveitis).
Phase:
Phase 3
Details
Lead Sponsor:
Lux Biosciences, Inc.